bioMérieux S.A. (EPA:BIM)
France · Delayed Price · Currency is EUR 94.30
+0.10 (0.11%)
Feb 19, 2026, 5:35 PM CET
bioMérieux Market Cap
bioMérieux has a market cap or net worth of €11.12 billion as of February 19, 2026. Its market cap has decreased by -18.04% in one year.
Market Cap
11.12B
Enterprise Value
11.25B
Revenue
4.12B
Ranking
n/a
PE Ratio
29.72
Stock Price
€94.30
Market Cap Chart
Since July 7, 2004, bioMérieux's market cap has increased from 1.18B to 11.12B, an increase of 839.66%. That is a compound annual growth rate of 10.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 18, 2026 | 11.12B | -14.60% |
| Dec 31, 2025 | 13.02B | 6.63% |
| Dec 31, 2024 | 12.21B | 2.78% |
| Dec 29, 2023 | 11.88B | 2.52% |
| Dec 30, 2022 | 11.59B | -21.58% |
| Dec 31, 2021 | 14.78B | 8.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 109.30B |
| Sanofi | 93.95B |
| Sartorius Stedim Biotech | 16.60B |
| Ipsen | 12.91B |
| Eurofins Scientific SE | 11.88B |
| ABIVAX Société Anonyme | 8.59B |
| Virbac | 3.06B |
| emeis Société anonyme | 2.50B |